Cozaar
Drug - Cozaar
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Losartan Potassium
Multiple ingredients are in alphabetical order.
Strength -
100MG
The potency of the active ingredient(s), Losartan Potassium. May repeat for multiple part products.
Applicant -
MERCK
The firm name holding legal responsibility for Cozaar. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
020386
The FDA assigned number to Cozaar. Format is nnnnnn.
Product Number -
003
The FDA assigned number to identify Cozaar. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Oct 13, 1998
The date Cozaar was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Cozaar. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Cozaar is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Merck Research Laboratories Div Merck Co Inc
The full name of the firm holding legal responsibility for the new application of Cozaar.
Cozaar
|
